Results 21 to 30 of about 514,317 (292)

How Can Immune Checkpoint Inhibitors Cause Hyperprogression in Solid Tumors?

open access: yesFrontiers in Immunology, 2020
Following the administration of immune checkpoint inhibitors, an unexpected pattern of response designated as hyperprogression may be observed in certain patients.
Morgane Denis   +6 more
doaj   +1 more source

Catch of the Day: New Serum Amyloid A (SAA) Antibody Is a Valuable Tool to Study Fish Health in Salmonids

open access: yesCells, 2023
Serum amyloid A (SAA) proteins belong to a family of acute-phase reactants, playing an integral role in defending the organism from pathological damage.
Ralfs Buks   +6 more
doaj   +1 more source

Antibody Representation Learning for Drug Discovery [PDF]

open access: yesarXiv, 2022
Therapeutic antibody development has become an increasingly popular approach for drug development. To date, antibody therapeutics are largely developed using large scale experimental screens of antibody libraries containing hundreds of millions of antibody sequences.
arxiv  

ASAP-SML: An Antibody Sequence Analysis Pipeline Using Statistical Testing and Machine Learning [PDF]

open access: yes, 2020
Antibodies are capable of potently and specifically binding individual antigens and, in some cases, disrupting their functions. The key challenge in generating antibody-based inhibitors is the lack of fundamental information relating sequences of antibodies to their unique properties as inhibitors.
arxiv   +1 more source

Anti-platelet factor 4/polyanion antibodies mediate a new mechanism of autoimmunity [PDF]

open access: yes, 2020
Antibodies recognizing complexes of the chemokine platelet factor 4 (PF4-CXCL4) and polyanions (P) opsonize PF4-coated bacteria hereby mediating bacterial host defense. A subset of these antibodies may activate platelets after binding to PF4-heparin complexes, causing the prothrombotic adverse drug reaction heparin-induced thrombocytopenia (HIT).
arxiv   +1 more source

Acknowledgement to Reviewers of Antibodies in 2017

open access: yesAntibodies, 2018
Peer review is an essential part in the publication process, ensuring that Antibodies maintains high quality standards for its published papers.[...]
Antibodies Editorial Office
doaj   +1 more source

Improving antibody language models with native pairing [PDF]

open access: yesarXiv, 2023
Current antibody language models are limited by their use of unpaired antibody sequence data and the biases in publicly available antibody sequence datasets, which are skewed toward antibodies against a relatively small number of pathogens. A recently published dataset (by Jaffe, et al) of approximately 1.6 x 10^6 natively paired human antibody ...
arxiv  

Broad Epitope Coverage of Therapeutic Multi-Antibody Combinations Targeting SARS-CoV-2 Boosts In Vivo Protection and Neutralization Potency to Corner an Immune-Evading Virus

open access: yesBiomedicines
Therapeutic antibodies (Abs) which act on a broader range of epitopes may provide more durable protection against the genetic drift of a target, typical of viruses or tumors.
Ilse Roodink   +20 more
doaj   +1 more source

Acknowledgement to Reviewers of Antibodies in 2013

open access: yesAntibodies, 2014
The editors of Antibodies would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2013.
Antibodies Editorial Office
doaj   +1 more source

When Two are Better than One: Modeling the Mechanisms of Antibody Mixtures [PDF]

open access: yes, 2019
It is difficult to predict how antibodies will behave when mixed together, even after each has been independently characterized. Here, we present a statistical mechanical model for the activity of antibody mixtures that accounts for whether pairs of antibodies bind to distinct or overlapping epitopes.
arxiv   +1 more source

Home - About - Disclaimer - Privacy